Another day, another delay for Novo's Catalent acquisition as FTC imposes 'Second Request' fkansteiner Fri, 05/03/2024 - 13:50

Established Brands: Under Pressure to do More with Less? Explore Options to Thrive. jpiatt Thu, 05/02/2024 - 10:00

Leo Pharma prepares to come for the topical JAK market as Incyte's Opzelura cream launch cools off zbecker Fri, 05/03/2024 - 10:56

Senator claims GSK pulled popular asthma med to dodge inhaler price caps fkansteiner Fri, 05/03/2024 - 09:54

Amgen's new Horizon products bolster top line despite continued Tepezza struggles kdunleavy Fri, 05/03/2024 - 07:16

Fierce Pharma Asia—Ono buys Deciphera for $2.4B; Novartis expands PeptiDream collab; WuXi Bio exits BIO 2024 aliu Thu, 05/02/2024 - 23:01